Alzheimers Dement (N Y) November 2017 PMID 29255791

Drug discovery and development: Role of basic biological research.

Richard C Mohs, Nigel H Greig

Full text PDF Download social card

Mentions

Peak: 5 in Aug 2021

across 4 sources since Dec 2019

Extended reach

63,040

potential audience

Total likes

495

Video views

58,520

Mentions per month

Dec 2019 – Apr 2024

Where it's discussed

News50 articles
X / Twitter6 posts
YouTube4 videos
Blogs3 articles

AI synopsis

What people are saying

Several contributions mention the challenging nature of the drug discovery process and the advantages of new medications, demonstrating a balanced understanding of the article's themes. The tone is informational, with phrases like 'offers benefits' and 'challenging process' reflecting a neutral but engaged perspective, emphasizing both the complexity and potential improvements in drug development.

AgreementModerate agreement

Most discussions acknowledge the importance of basic biological research in drug development, showing general agreement with the publication's emphasis.

InterestModerate interest

Participants show a moderate level of curiosity, highlighting interesting points like safety benefits and process challenges, but not expressing strong enthusiasm.

EngagementModerate engagement

The posts demonstrate some engagement by referring to specific benefits and challenges, yet lack deep analysis or detailed elaboration.

ImpactModerate impact

The discussions suggest recognition of the article's relevance but do not indicate transformative influence or widespread calling for change.

Abstract in brief

The article explains that drug discovery and development is a long, complex, and costly process that involves identifying and testing many biological targets to find effective medicines.
It emphasizes the importance of basic biological research in understanding these targets and developing new tools to investigate them, which can improve the efficiency and success rate of bringing new drugs to market.
The authors encourage scientists to frame their research in ways that connect with the broader drug development process, helping to translate preclinical findings into human treatments and address key scientific and operational challenges.]

Read the full abstract